Paul Krack Selected Research

Paul Krack Research Topics

Disease

90	Parkinson Disease (Parkinson's Disease) 02/2022 - 01/2002
12	Dyskinesias (Dyskinesia) 11/2021 - 04/2002
11	Movement Disorders (Movement Disorder) 01/2021 - 06/2006
10	Tremor (Tremors) 01/2021 - 06/2006
9	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 05/2011
8	Dystonia (Limb Dystonia) 12/2019 - 01/2002
7	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2021 - 05/2012
3	Essential Tremor (Essential Tremors) 01/2018 - 06/2011
3	Mental Disorders (Mental Disorder) 01/2015 - 10/2010
2	Dementia (Dementias) 01/2020 - 11/2011
2	Tourette Syndrome (Tourette's Syndrome) 12/2019 - 01/2019
2	Anhedonia 05/2013 - 01/2006
2	Cognitive Dysfunction 12/2012 - 01/2002
2	Dystonic Disorders (Writer's Cramp) 06/2011 - 08/2009
1	Brain Diseases (Brain Disorder) 01/2021
1	REM Sleep Behavior Disorder 01/2021
1	COVID-19 05/2020
1	Postoperative Cognitive Complications 01/2020
1	Torticollis (Wryneck) 12/2019
1	Lethargy 09/2019
1	Chorea (Rheumatic Chorea) 01/2018
1	Substance-Related Disorders (Drug Abuse) 01/2015
1	Rare Diseases (Rare Disease) 09/2014
1	Dopa-responsive Dystonia 09/2014
1	Weight Gain 01/2014
1	Hypercapnia 04/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2013
1	Cerebral Palsy (Spastic Diplegia) 08/2009
1	Intractable Pain 01/2009
1	Gambling (Pathological Gambling) 11/2006
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2006
1	Hypokinesia (Bradykinesia) 06/2006
1	Aphonia 11/2005
1	Dysarthria (Spastic Dysarthria) 11/2005
1	Headache (Headaches) 05/2004
1	Tension-Type Headache (Tension Headache) 05/2004
1	Fatigue 05/2003
1	Mood Disorders (Mood Disorder) 05/2003
1	Contusions 01/2002
1	Hematoma 01/2002

Drug/Important Bio-Agent (IBA)

25	Levodopa (L Dopa)FDA LinkGeneric 09/2021 - 01/2002
13	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 11/2006
6	Pharmaceutical PreparationsIBA 12/2021 - 04/2002
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
2	propylene diquat (PDQ(+))IBA 01/2022 - 01/2019
2	Botulinum Toxins (Botulinum Toxin)IBA 12/2019 - 05/2004
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 12/2018
2	Dopamine Agonists (Dopamine Agonist)IBA 12/2018 - 05/2013
2	Dopamine Agents (Dopaminergic Agents)IBA 05/2012 - 08/2002
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 12/2021
1	benzylamineIBA 12/2021
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Apomorphine FDA Link 09/2019
1	Guanosine Triphosphate (GTP)IBA 09/2014
1	Biological ProductsIBA 09/2014
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 09/2014
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 09/2014
1	Piribedil (Trivastal)IBA 05/2013
1	Glutamic Acid (Glutamate)FDA Link 12/2007
1	Type A Botulinum Toxins (Botox)FDA Link 05/2004
1	Analgesics (Analgesic Drugs)IBA 05/2004
1	abobotulinumtoxinA FDA Link 05/2004

Therapy/Procedure

71	Deep Brain Stimulation 02/2022 - 01/2002
16	Therapeutics 04/2021 - 04/2002
6	Electrodes (Electrode) 06/2011 - 01/2002
5	Denervation 12/2021 - 04/2010
3	Pallidotomy 01/2018 - 01/2009
3	Microelectrodes 11/2016 - 01/2002
1	Activities of Daily Living (ADL) 01/2022
1	Aftercare (After-Treatment) 11/2015
1	Contraindications 11/2011
1	Psychosurgery (Lobotomy) 10/2010
1	Operative Surgical Procedures 08/2009
1	Spinal Cord Stimulation 01/2009
1	Replantation 05/2008
1	Implanted Electrodes 04/2007